Japan aims to fast-track review of coronavirus anti-viral drug remdesivir
Health Minister Katsunobu Kato's comment comes after remdesivir was granted emergency use authorization by the US Food and Drug Administration for COVID-19 on Friday.
An ampule of drug Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (COVID-19) continues(photo credit: ULRICH PERREY/POOL VIA REUTERS)ByREUTERS
